Cite
Steinhausen E, Lefering R, Glombitza M, et al. Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021). J Bone Jt Infect. 2021;6(6):203-205doi: 10.5194/jbji-6-203-2021.
Steinhausen, E., Lefering, R., Glombitza, M., Brinkmann, N., Vogel, C., Mester, B., & Dudda, M. (2021). Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021). Journal of bone and joint infection, 6(6), 203-205. https://doi.org/10.5194/jbji-6-203-2021
Steinhausen, Eva, et al. "Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021)." Journal of bone and joint infection vol. 6,6 (2021): 203-205. doi: https://doi.org/10.5194/jbji-6-203-2021
Steinhausen E, Lefering R, Glombitza M, Brinkmann N, Vogel C, Mester B, Dudda M. Reply to McNally's comment on "Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions - a single center experience" by Steinhausen et al. (2021). J Bone Jt Infect. 2021 May 27;6(6):203-205. doi: 10.5194/jbji-6-203-2021. eCollection 2021. PMID: 34123710; PMCID: PMC8188879.
Copy
Download .nbib